How much does Farxiga cost with Medicare?
Farxiga can cost up to $600 without insurance, with costs varying by pharmacy and whether you choose the brand or the generic. With Medicare coverage, your out-of-pocket costs depend on your plan.
Farxiga (dapagliflozin) is a medication for helping lower blood sugar levels and reduce the risk of heart and kidney issues for those with type 2 diabetes, heart failure, or chronic kidney disease.
With Medicare, drug overage usually comes through a Medicare Part D or a Medicare Advantage Prescription Drug (MAPD) plan. But whether your plan covers Farxiga and how much the drug will cost after coverage depends on your plan.
How much does Farxiga cost per month with Medicare?
Depending on where you get it, the cost of Farxiga without insurance can be over $600. The generic version, dapagliflozin, still costs more than $400.
Farxiga can be covered by Medicare Part D or a MAPD plan. However, whether this medication or its generic version is covered by your Medicare drug plan and how much the plan will cover depends on its specific list of covered drugs, called a formulary. Private insurers manage Medicare drug plans and will have a different list depending on the plan.
In addition, keep in mind that Medicare drug plans also have a deductible, premium, and copay that can vary depending on the plan. In 2025, the national base beneficiary premium for Part D is $36.78. According to the Centers for Medicare & Medicaid Services (CMS), the average monthly premium for Medicare Advantage plans is $17.
What tier is Farxiga on?
Within your plan's formulary, the insurer will place Farxiga in a tier. Generally, the higher the tier, the more you'll pay as a copayment, with the generic version typically in a lower tier than the brand-name drug.
Many Medicare drug plans should include Farxiga, though its tier will depend on your plan. If your plan doesn't include this drug, it may include an alternative and equally effective medication. Generally, Medicare drug plans must cover at least two drugs from the most commonly prescribed categories.
If the plan includes it and classifies it in a higher tier, your insurer may require prior authorization for coverage, which could include Step Therapy. This means you'll be asked to try a different, equally effective, but more cost-effective medication first before Medicare will approve coverage for Farxiga.
Takeaway
Farxiga is a drug designed to help lower blood sugar levels and reduce the risk of heart and kidney issues for those with type 2 diabetes, heart failure, or chronic kidney disease. Without insurance, the cost of Farxiga can range from around $400 to $600, depending on the pharmacy and whether you choose the brand-name or generic version.
Usually, Medicare drug coverage comes through a Medicare Part D plan. While your exact coverage and costs for Farxiga depend on the specifics of your plan, many Medicare plans should cover this medication. Plus, once Medicare's price negotiation agreement starts in 2026, the price with coverage should be more affordable.
The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
WA facility caring for drug-exposed newborns at risk of closure after state funding cut
(Getty Images) The only medical facility focused on caring for drug-exposed babies in western Washington is pleading for help after Gov. Bob Ferguson vetoed its funding and the state abruptly canceled its contract. And a group of GOP lawmakers is urging Ferguson to find a way to keep the Kent facility operating. For decades, the Pediatric Interim Care Center has tended to babies born to mothers with substance use disorder. Just under half of its annual $1.7 million budget has usually come from the state, said Development Director Elaine Purchase. Fundraising makes up the rest. But this year, lawmakers slashed that funding to $100,000 in the face of a steep budget shortfall. The facility, known as PICC, was ready to make do with the deep cut and dip into its reserves, with the hope of making up for it when the Legislature returns next year. Then last month, Ferguson vetoed even that $100,000, as part of a slew of small items he removed to save money in the $78 billion two-year spending plan. And soon after, Purchase was 'blindsided' when the state Department of Children, Youth and Families cut its contract with the nursery, meaning no more babies would be referred there starting July 1. 'Which basically destroys our program,' Purchase said. 'Why would they abandon it for $100,000?' In a statement, the Department of Children, Youth and Families argued the center's state funding was 'not cost-effective.' Secretary Tana Senn said the center received money for its 13 beds regardless of how many babies it was serving, and didn't meet requirements to get Medicaid funding. 'We also want to clarify that DCYF is not shutting down the Kent PICC,' said Senn, a former state lawmaker. 'They can still accept referrals from hospitals and have informed DCYF on multiple occasions that they have sufficient charitable funding to continue serving children.' On Friday, state House Republican leadership, including Minority Leader Drew Stokesbary, of Auburn, took issue with the rationale and urged the state agency and Ferguson to reverse course. 'Governor Ferguson, throughout your first legislative session as governor, you said that you just wanted to do things that are 'common sense,'' the half-dozen lawmakers wrote. 'What is more common sense than using the power you hold to save the lives of innocent newborn babies?' The facility, open for 35 years, was caring for just one newborn Friday, said Purchase. It has been underused as the focus has shifted to keeping babies with their parents. Research has indicated parental involvement is integral in an infant's development. 'New evidence-based models demonstrate better outcomes for babies when they 'room in' at hospitals under the care of a physician or are in transitional care homes that allow the mother and baby to stay together,' Senn said. 'While hospitals, of course, may choose to continue to refer children to the Kent PICC, they have been doing so much less frequently as demonstrated by the current empty beds at the Kent PICC,' the agency secretary continued. 'Instead, hospitals more often refer infants to other facilities that use the current standard of care.' In 2021, the Legislature passed a measure known as the Keeping Families Together Act to help relatives take care of children who can't stay with their parents and to reduce racial disparities in the child welfare system. Critics blame the bipartisan law for a reported increase in child deaths, including from drug exposure. The average stay for babies at the Kent pediatric care center is 30 to 40 days. Most are exposed to fentanyl or methamphetamine. Since opening in 1990, the facility says it has cared for over 3,500 babies. 'We just want there to be a safe place for these little ones,' Purchase said. The governor did not provide comment on Friday, with a spokesperson for his office referring to the statement from the Department of Children, Youth and Families.
Yahoo
an hour ago
- Yahoo
From Toxic Rage to Midlife Clarity: Katie Fogarty on the Power of Naming Menopause
On Tuesday evening, Flow Space hosted an intimate gathering to celebrate the release of Midlife Private Parts: Revealing Essays That Will Change the Way You Think About Age. Among all of the standout voices was Katie Fogarty, podcaster, career coach and author of the searingly honest essay 'Toxic Rage.' 'I want a divorce,' her piece begins. 'Four words detonating a sunny day, shouted in my gravel driveway at my college boyfriend husband of 24 years.' It's a dramatic opener, but not for drama's sake. It's a symptom. A red flag. A hormonal thunderstorm rolling through the landscape of a marriage. More from Flow Space The Surprising Workout That Could Heal Your Knee Pain Fogarty's essay recounts the emotional volatility and confusion that arrived—unannounced and unrecognized—as she entered menopause. 'I felt crazy,' she writes. 'Most of the time.' 'For many years, I never thought about menopause at all,' she told the audience of the Tuesday night event. 'And if I did think about it, I associated it with hot flashes, right? Because they have an excellent publicist.' 'So when I never had a hot flash, I didn't think I was in menopause, but I had months and months of sleep interruptions,' she continued. 'I had what my doctor called 'mood instability,' which sounds very genteel, but actually was presenting more like toxic, volcanic fury, and the film was tearfulness, unexplained… Like, I couldn't manage my emotions. I felt like a toddler at times, and my brain had been hijacked.' At the time, Fogarty had just launched her podcast A Certain Age, and was beginning to hear echoes of her experience from guests and listeners: rage, sleep loss, disconnection, depression, even suicidal ideation. 'It's insane that all of these well educated women who are so powerful in so many areas of their life don't have enough information [around menopause]' she said at the event. 'And I felt angry again about how underserved so many women are, and that there are a lot of toolsthat are available that can really help.' Her essay, like her podcast, aims to name what's too often unnamed. She describes the physiological derailment of midlife hormones and the emotional toll of feeling unmoored. It's deeply personal—but it's also a rallying cry. Fogarty's story doesn't end in that driveway. 'Slowly, my husband and I made some changes,' she writes. 'Time passed, and I became more steady, solid.' Hormone therapy, communication, great lube and sheer persistence helped her reclaim joy and connection—with herself and with her husband. The final scene? The two of them laughing uncontrollably in a supermarket aisle, 'holding an artichoke,' the rage now replaced by love and absurdity. It's a reminder that naming our pain is the first step to healing. As Fogarty puts it: 'How did I get here?' In asking that question—not just in despair, but later, in gratitude—she gives all of us permission to do the same.
Forbes
an hour ago
- Forbes
Men's Health At Work: A Silent Threat To Culture And Productivity
Men's health in the workplace is a silent issue brewing. In Corporate America, you'll rarely hear male leaders admit they "need a break" or openly ask for help. Yet behind the scenes, many high-performing men are silently burning out, neglecting their well-being, and pushing onward until something breaks. Men's health is lagging behind that of women. As of 2023, U.S. men live, on average, 5.3 years fewer than women—75.8 years compared to 81.1. As it pertains to the workplace, according to the Journal of Occupational and Environmental Medicine, psychological distress in men drives $8,432 per person annually in presenteeism losses and $2,796 in absenteeism, which is double the impact seen in women. June may be Men's Health Month, but for corporate America, men's health needs a 365-day focus. The cost of ignoring it is significant: diminished productivity, increasing healthcare claims, leadership attrition, and untapped potential not realized. Addressing this requires reframing men's health and how organizations approach performance, well-being, and leadership sustainability, starting with these three foundational shifts. Rest Doesn't Equate To Weakness Or Lower Ambition In many high-pressure environments, rest is viewed as a luxury or, worse, a risk. Taking a break can feel like you're falling behind. This mentality quietly undermines leaders' ability to operate at their highest level. Just as athletes suffer when recovery is skipped, so too do executives. When rest and circadian-aligned living are neglected, judgment erodes, creativity stagnates, and leaders become reactive rather than responsive. As burnout and retention strategist Chazz Scott shared, "Most people can't say, 'I took a break today and still felt successful.'" That quiet guilt, he noted, is deeply embedded in many male leaders and often stems from inherited beliefs that rest equals weakness. However, the reality is the opposite. Rest, recovery, and restoration aren't the enemies of ambition. Instead, they're essential components of your optimal performance infrastructure. Ignoring these pillars doesn't just affect the leader; it affects everyone downstream. Leaders can build systems and cultures that support performance and recovery through: Well-Being Isn't A One-Size-Fits-All Equation There's been a much-needed shift toward prioritizing well-being in the workplace. However, most initiatives still fall short. While meditation apps and fitness challenges are well-intentioned, they often miss the mark, especially for male leaders navigating unique physiological, cultural, and socioeconomic stressors. Health risks are not distributed equally. Black men, for instance, face significantly higher rates of hypertension, cardiovascular disease, and chronic stress, regardless of income level or professional title. Potential reasoning for this is, in some circles, attributed to what researchers call the weathering effect: the cumulative toll of enduring racialized stress over time, which accelerates biological aging and worsens long-term health outcomes. As Justin Grant, author of Company Men: A Wellness Guide for Black Men in Corporate America, shares, the higher Black men rise in corporate spaces, the more likely they are to experience anxiety, isolation, and declining health. And they're not alone. Latino, Asian, and even first-generation professionals each face distinct challenges that generic wellness programs don't address. A more precise and culturally strong wellness strategy might start with: Guard Your Mind And Don't Marginalize Yourself For many male leaders, performance and identity become inseparable. Output becomes an ever-growing proxy for self-worth. Titles become personalities. And over time, the line between the person and position blurs. In this environment, mental health isn't just about managing stress. It's about preserving a sturdy sense of self. As Scott noted, when leaders operate in emotional isolation, they lose what he calls "social capital": the trust, rapport, and influence required for meaningful and effective leadership. The health risks are serious. A study published in World Psychiatry found that isolation and a lack of social support increase the risk of burnout, anxiety, depression, and PTSD in professionals—no amount of success or compensation shields against this erosion. High performance doesn't require abandoning your identity. Yet many men, in pursuit of growth and achievement, entirely sacrifice their hobbies, passions, and relationships, only to arrive at the top with fractured lives. Leaders rooted in their identity and a strong sense of self, rather than just achievement and accolades, tend to be more resilient. Organizations can support this by: Men's Health in Corporate America Men's health struggles don't show up on quarterly reports until it's too late. By then, they've already surfaced as stalled leadership pipelines, costly turnover, disengaged teams, and declining innovation. High-performing men aren't immune to exhaustion, disconnection, or identity loss. They're often the most skilled at hiding it. When that happens, companies not only lose talent but also trust, longevity, and untapped potential. Much like women's health, the well-being of your male leaders isn't just a personal matter; it's a business imperative. And it's also key to winning the future of work.
